This site uses cookies, tags, and tracking settings to store information that help give you the very best browsing experience. Dismiss this warning

Infection Dynamics of Sylvatic Dengue Virus in a Natural Primate Host, the African Green Monkey

Kathryn A. Hanley Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Kathryn A. Hanley in
Current site
Google Scholar
PubMed
Close
,
Mathilde Guerbois Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Mathilde Guerbois in
Current site
Google Scholar
PubMed
Close
,
Tiffany F. Kautz Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Tiffany F. Kautz in
Current site
Google Scholar
PubMed
Close
,
Meredith Brown Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Meredith Brown in
Current site
Google Scholar
PubMed
Close
,
Stephen S. Whitehead Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Stephen S. Whitehead in
Current site
Google Scholar
PubMed
Close
,
Scott C. Weaver Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Scott C. Weaver in
Current site
Google Scholar
PubMed
Close
,
Nikos Vasilakis Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Nikos Vasilakis in
Current site
Google Scholar
PubMed
Close
, and
Preston A. Marx Department of Biology, New Mexico State University, Las Cruces, New Mexico; Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Maryland; Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas; Institute for Human Infections and Immunity and Center for Tropical Diseases, University of Texas Medical Branch, Galveston, Texas; Tulane National Primate Research Center, Tulane University, Covington, Louisiana

Search for other papers by Preston A. Marx in
Current site
Google Scholar
PubMed
Close
Restricted access

The four serotypes of mosquito-borne dengue virus (DENV-1, -2, -3, and -4) that circulate in humans each emerged from an enzootic, sylvatic cycle in non-human primates. Herein, we present the first study of sylvatic DENV infection dynamics in a primate. Three African green monkeys were inoculated with 105 plaque-forming units (pfu) DENV-2 strain PM33974 from the sylvatic cycle, and one African green monkey was inoculated with 105 pfu DENV-2 strain New Guinea C from the human cycle. All four monkeys seroconverted (more than fourfold rise in 80% plaque reduction neutralization titer [PRNT80]) against the strain of DENV with which they were inoculated; only one (33%) of three monkeys infected with sylvatic DENV showed a neutralizing antibody response against human-endemic DENV. Virus was detected in two of three monkeys inoculated with sylvatic DENV at low titer (≤ 1.3 log10pfu/mL) and brief duration (≤ 2 days). Clinical signs included rash and elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels.

Author Notes

* Address correspondence to Kathryn A. Hanley, Department of Biology, New Mexico State University, Foster Hall, Las Cruces, NM 88003. E-mail: khanley@nmsu.edu

Financial support: This project was supported by National Center for Research Resources and Office of Research Infrastructure Programs, National Institutes of Health (NIH) Grant P51 RR00164-50, National Center for Research Resources Grant 5P20RR016480-12, and National Institute of General Medical Sciences, NIH Grant 8 P20 GM103451-12. Support was also provided, in part, by the National Institute of Allergy and Infectious Diseases Intramural Research Program, NIH.

Authors' addresses: Kathryn A. Hanley, Department of Biology, New Mexico State University, Las Cruces, NM, E-mail: khanley@nmsu.edu. Mathilde Guerbois, Scott C. Weaver, and Nikos Vasilakis, Center for Tropical Diseases, Department of Pathology and Center for Biodefense and Emerging Infectious Diseases and Institute for Human Infections and Immunity, Center for Tropical Diseases, University of Texas Medical Branch, Galveston, TX, E-mails: mathildeguerbois@yahoo.fr, sweaver@utmb.edu, and nivasila@utmb.edu. Tiffany F. Kautz, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, E-mail: tfkautz@utmb.edu. Meredith Brown, Banfield Pet Hospital, Las Cruces, NM, E-mail: Meredith.Brown@banfield.net. Stephen S. Whitehead, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, E-mail: swhitehead@niaid.nih.gov. Preston A. Marx, Division of Microbiology, Tulane National Primate Research Center, Covington, LA, E-mail: pmarx@tulane.edu.

  • 1.

    Hanley KA, Monath TP, Weaver SC, Rossi SL, Richman RL, Vasilakis N, 2013. Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol 19: 292311.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Kurane I, Ennis FE, 1992. Immunity and immunopathology in dengue virus infections. Semin Immunol 4: 121127.

  • 3.

    Sabin AB, 1952. Research on dengue during World War II. Am J Trop Med Hyg 1: 3050.

  • 4.

    Whitehead SS, Blaney JE, Durbin AP, Murphy BR, 2007. Prospects for a dengue virus vaccine. Nat Rev Microbiol 5: 518528.

  • 5.

    Althouse BM, Durbin AP, Hanley KA, Halstead SB, Weaver SC, Cummings DA, 2014. Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis. Virology 452–453: 237246.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Nguyet MN, Duong TH, Trung VT, Nguyen TH, Tran CN, Long VT, Dui le T, Nguyen HL, Farrar JJ, Holmes EC, Rabaa MA, Bryant JE, Nguyen TT, Nguyen HT, Nguyen LT, Pham MP, Nguyen HT, Luong TT, Wills B, Nguyen CV, Wolbers M, Simmons CP, 2013. Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes. Proc Natl Acad Sci USA 110: 90729077.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Vasilakis N, Cardosa J, Hanley KA, Holmes EC, Weaver SC, 2011. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol 9: 532541.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Monlun E, Zeller H, Traore-Lamizana M, Hervy JP, Adam F, Mondo M, Digoutte JP, 1992. Caracteres cliniques et epidemiologiques de la dengue 2 au Senegal. Med Mal Infect 22: 718721.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Robin Y, Cornet M, Heme G, Le Gonidec G, 1980. Isolement du virus dela dengue au Senegal. Ann Virol 131: 149154.

  • 10.

    Saluzzo JF, Cornet M, Adam C, Eyraud M, Digoutte JP, 1986. Dengue 2 in eastern Senegal: serologic survey in simian and human populations. 1974–85. Bull Soc Pathol Exot 79: 313322.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Saluzzo JF, Cornet M, Castagnet P, Rey C, Digoutte JP, 1986. Isolation of dengue 2 and dengue 4 viruses from patients in Senegal. Trans R Soc Trop Med Hyg 80: 5.

  • 12.

    Carey DE, 1963. Use of a combined complement-fixing antigen to detect arthropod-borne viral infection. Nature 200: 10241025.

  • 13.

    Vasilakis N, Tesh RB, Weaver SC, 2008. Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg Infect Dis 14: 502504.

  • 14.

    Cardosa J, Ooi MH, Tio PH, Perera D, Holmes EC, Bibi K, Abdul Manap Z, 2009. Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever. PLoS Negl Trop Dis 3: e423.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Franco C, Hynes NA, Bouri N, Henderson DA, 2010. The dengue threat to the United States. Biosecur Bioterror 8: 273276.

  • 16.

    Althouse BM, Lessler J, Sall AA, Diallo M, Hanley KA, Watts DM, Weaver SC, Cummings DA, 2012. Synchrony of sylvatic dengue isolations: a multi-host, multi-vector SIR model of dengue virus transmission in Senegal. PLoS Negl Trop Dis 6: e1928.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Carrara AS, Gonzales G, Ferro C, Tamayo M, Aronson J, Paessler S, Anishchenko M, Boshell J, Weaver SC, 2005. Venezuelan equine encephalitis virus infection of spiny rats. Emerg Infect Dis 11: 663669.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Del Amo J, Llorente F, Figuerola J, Soriguer RC, Moreno AM, Cordioli P, Weissenbock H, Jimenez-Clavero MA, 2014. Experimental infection of house sparrows (Passer domesticus) with West Nile virus isolates of Euro-Mediterranean and North American origins. Vet Res 45: 33.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Mandl JN, Akondy R, Lawson B, Kozyr N, Staprans SI, Ahmed R, Feinberg MB, 2011. Distinctive TLR7 signaling, type I IFN production, and attenuated innate and adaptive immune responses to yellow fever virus in a primate reservoir host. J Immunol 186: 64066416.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Durbin AP, Karron RA, Sun W, Vaughn DW, Reynolds MJ, Perreault JR, Thumar B, Men R, Lai CJ, Elkins WR, Chanock RM, Murphy BR, Whitehead SS, 2001. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am J Trop Med Hyg 65: 405413.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21.

    Hanley KA, Manlucu LR, Manipon GG, Hanson CT, Whitehead SS, Murphy BR, Blaney JE Jr, 2004. Introduction of mutations into the non-structural genes or 3′ untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity. Vaccine 22: 34403448.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Whitehead SS, Hanley KA, Blaney JE Jr, Gilmore LE, Elkins WR, Murphy BR, 2003. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys. Vaccine 21: 43074316.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Durbin AP, Whitehead SS, McArthur J, Perreault JR, Blaney JE Jr, Thumar B, Murphy BR, Karron RA, 2005. rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. J Infect Dis 191: 710718.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Vasilakis N, Fokam EB, Hanson CT, Weinberg E, Sall AA, Whitehead SS, Hanley KA, Weaver SC, 2008. Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains. Virology 377: 296307.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Vasilakis N, Shell EJ, Fokam EB, Mason PW, Hanley KA, Estes DM, Weaver SC, 2007. Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology 358: 402412.

  • 26.

    Bray M, Men R, Tokimatsu I, Lai CJ, 1998. Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J Virol 72: 16471651.

  • 27.

    Hanley KA, Nelson JT, Schirtzinger EE, Whitehead SS, Hanson CT, 2008. Superior infectivity for mosquito vectors contributes to competitive displacement among strains of dengue virus. BMC Ecol 8: 1.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Vasilakis N, Durbin AP, da Rosa AP, Munoz-Jordan JL, Tesh RB, Weaver SC, 2008. Antigenic relationships between sylvatic and endemic dengue viruses. Am J Trop Med Hyg 79: 128132.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Blaney JE Jr, Durbin AP, Murphy BR, Whitehead SS, 2006. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral Immunol 19: 1032.

  • 30.

    Wahala WM, Donaldson EF, de Alwis R, Accavitti-Loper MA, Baric RS, de Silva AM, 2010. Natural strain variation and antibody neutralization of dengue serotype 3 viruses. PLoS Pathog 6: e1000821.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Alvarez M, Pavon-Oro A, Rodriguez-Roche R, Bernardo L, Morier L, Sanchez L, Alvarez AM, Guzman MG, 2008. Neutralizing antibody response variation against dengue 3 strains. J Med Virol 80: 17831789.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Kato F, Ishida Y, Kawagishi T, Kobayashi T, Hishiki T, Miura T, Igarashi T, 2013. Natural infection of cynomolgus monkeys with dengue virus occurs in epidemic cycles in the Philippines. J Gen Virol 94 (Pt 10): 22022207.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Halstead SB, Shotwell H, Casals J, 1973. Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection. J Infect Dis 128: 714.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Liddie S, Goody RJ, Valles R, Lawrence MS, 2010. Clinical chemistry and hematology values in a Caribbean population of African green monkeys. J Med Primatol 39: 389398.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Cassetti MC, Durbin A, Harris E, Rico-Hesse R, Roehrig J, Rothman A, Whitehead S, Natarajan R, Laughlin C, 2010. Report of an NIAID workshop on dengue animal models. Vaccine 28: 42294234.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36.

    Casaco A, Beausoleil I, Gonzalez B, Luaces P, Leon A, Arteaga ME, Prado P, Rodriguez V, Perez A, Guevara G, Bada AM, Ledon N, Fuentes D, Gonzalez C, Hernandez O, Orphee R, Blanco D, Garcia-Osuma M, Ballester-Labrada A, 2010. Hematological, biochemical, respiratory, cardiovascular and electroneurophysiological parameters in African green monkeys (Cercopithecus aethiops sabaeus). Its use in non-clinical toxicological studies. J Med Primatol 39: 177186.

    • PubMed
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 1151 942 376
Full Text Views 423 23 0
PDF Downloads 154 18 2
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save